ERBB2 and gastric cancer: Human epidermal growth factor receptor 2 (HER2) is a receptor tyrosine kinase (RTK) that regulates cell growth and differentiation signaling pathways and is greatly overexpressed in approximately 20% to 25% of breast [1, 2] and 30% of gastric cancers [3], leading to an aggressive tumor phenotype and dismal prognosis.